Open AccessUnderlying IgM heavy chain amyloidosis in treatment-refractory IgA nephropathy: A case report
Author(s) -
Haiting Wu,
Yubing Wen,
Wei Ye,
Liu Bingyan,
Kaini Shen,
Ruitong Gao,
Mingxi Li
Publication year - 2019
Publication title -
world journal of clinical cases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v7.i19.3055
Subject(s) - medicine , amyloidosis , monoclonal gammopathy of undetermined significance , nephrotic syndrome , nephropathy , proteinuria , renal biopsy , malignancy , bortezomib , renal function , pathology , kidney , gastroenterology , monoclonal , multiple myeloma , immunology , monoclonal antibody , antibody , endocrinology , diabetes mellitus
Monoclonal immunoglobulin can cause renal damage, with a wide spectrum of pathological changes and clinical manifestations without hematological evidence of malignancy. These disorders can be missed, especially when combined with other kidney diseases.